Zim Laboratories Ltd - Press Release For Grant Of Marketing Authorization For Azithromycin For Oral Suspension 200 Mg/5Ml (40 Mg/Ml) In Portugal, Europe

Please find enclosed press release for grant of marketing authorisation for Azithromycin for oral suspension 200 mg / 5 ml (40 mg/ml) in Portugal, Europe to the wholly owned European subsidiary of the Company.